Effect of 17β-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Do Nascimento, Carlos Antonio ^a   Kauser, Katalin ^b   Rubanyi, Gabor M ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b BAYER AG   (Germany)

Author keywords

Atheroclerosis; N( ) nitro L arginine methyl ester; Nitric oxide

Indexed keywords

ARGININE METHYL ESTER; ESTRADIOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; ACETYLCHOLINE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; GLYCERYL TRINITRATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN ACTIVITY; FEMALE; HYPERCHOLESTEROLEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; ANIMAL; AORTA; ARTERIOSCLEROSIS; BLOOD; DRUG ANTAGONISM; ENZYMOLOGY; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; ARTERIOSCLEROSIS; CHOLESTEROL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ESTRADIOL; FEMALE; HYPERCHOLESTEROLEMIA; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROGLYCERIN; RABBITS; VASODILATION; VASODILATOR AGENTS;

EID: 0033125326     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.5.h1788     Document Type: Article

References (29)

1. Arnal, J. F., S. Clamens, C. Pechet, A. Negre-Salvayre, C. Allera, J.-P. Girolami, R. Salvayres, and F. Bayard. Ethinyl-estradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc. Natl. Acad. Sci. USA 93: 4108-4113, 1996.
2. Candipan, R. C., B.-Y. Wang, P. S. Tsao, and J. P. Cooke. Regression or progression: dependency upon vascular nitric oxide activity. Arterioscler. Thromb. Vasc. Biol. 16: 44-50, 1996.
3. Cayatte, A. J., J. J. Palacino, K. Horten, and R. A. Cohen. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14: 753-759, 1994.
4. Cooke, J. P., and V. J. Dzau. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 96: 379-382, 1997.
5. Cooke, J. P. A., H. Singer, P. Tsao, P. Zera, R. A. Rowan, and M. E. Billingham. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90: 1168-1172, 1992.
6. Creager, M. A., S. J. Callagher, X. J. Girerd, S. M. Coleman, V. J. Dzau, and J. P. Cooke. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90: 1248-1253, 1992.
7. Elhage, R., F. Bayard, V. Richard, P. Holvoet, N. Duverger, C. Fiévet, and J.-F. Arnal. Prevention of fatty streak formation of 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 96: 3048-3052, 1997.
8. Farhat, M. Y., M. C. Lavigne, and P. W. Ramwell. The vascular protective effects of estrogen. FASEB J. 10: 615-624, 1996.
9. Geotz, R. M., I. Morano, T. Calvoni, R. Studer, and J. Holtz. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem. Biophys. Res. Commun. 205: 905-910, 1994.
10. Gilligan, D. M., A. A. Quyyumi, R. O. Cannon III, G. B. Johnson, and W. H. Schenke. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89: 2545-2551, 1994.
11. Harrison, D. G. Endothelial dysfunction in atherosclerosis. Basic Res. Cardiol. 89, Suppl. I: 87-102, 1994.
12. Hayashi, T., J. M. Fujuto, L. J. Ignarro, and G. Chaudhuri. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc. Natl. Acad. Sci. USA 89: 11259-11263, 1992.
13. Hayashi, T. K., K. Yamada, T. Esaki, M. Kuzuy, S. Satake, T. Ishikawa, H. Hidaka, and A. Iguchi. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem. Biophys. Res. Commun. 214: 847-855, 1995.
14. Hishikawa, K., T. Makaki, T. Marumo, H. Suzuki, R. Kato, and T. Saruta. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 36: 291-293, 1995.
15. Holm, P., N. Korsgaard, M. Shalmi, H. L. Andersen, P. Hougaard, S. O. Skouby, and S. Slender. Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J. Clin. Invest. 100: 821-828, 1997.
16. Holm, P., S. Stender, H. O. Andersen, B. F. Hansen, and B. G. Nordestgaard. Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits. Arterioscler. Thromb. Vasc. Biol. 17: 1504-1511, 1997.
17. Jeremy, R. W., H. McCarron, and D. Sullivan. Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilation in the hypercholesterolemic rabbit. Circulation 94: 498-506, 1996.
18. Kauser, K., and G. M. Rubanyi. Potential cellular signaling mechanism mediating upregulation of endothelial nitric oxide production by estrogen. J. Vasc. Res. 34: 229-236, 1997.
19. Kauser, K., and G. M. Rubanyi. Vasculoprotection by estrogen contributes to gender difference in cardiovascular diseases: potential mechanism and role of endothelium. In: The Endothelium in Clinical Practice, edited by G. M. Rubanyi and V. J. Dzau. New York: Dekker, 1997, p. 439-467.
20. Kleinert, H., T. Wallerath, C. Euchenhofer, I. Ihrig-Biedert, H. Li, and U. Förstermann. Estrogens increase transcription of the human endothelial NO synthase gene analysis of the transcription factors involved. Hypertension 31: 582-588, 1998.
21. Mancini, G. B. J., G. C. Henry, C. Macaya, B. J. O'Neill, A. L. Pucillo, R. G. Carere, T. J. Wargovich, H. Mudra, T. F. Luscher, M. I. Klibaner, H. E. Haber, A. C. G. Uprichard, C. J. Pipene, and B. Pitt. Angiotension-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TRENP (trial on reversing endothelial dysfunction) study. Circulation 94: 258-265, 1996.
22. Naruse, K. M., M. Shimizu, M. Muramatsu, Y. Toki, Y. Miyazaki, K. Okurama, H. Hashimoto, and T. Ito. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. Arterioscler. Thromb. 14: 746-756, 1994.
23. Nathan, L., and G. Chaudhuri. Estrogens and atherosclerosis. Annu. Rev. Pharmacol. Toxicol. 37: 477-515, 1997.
24. Otsuji, S., O. Nakajima, S. Waku, K. Shigeyuki, H. Hosokawa, I. Kinoshita, T. Okubo, S. Tamoto, K. Takada, T. Ishihara, and N. Osawa. Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis. Am. Heart J. 129: 1094-1100, 1995.
25. Rubanyi, G. M., A. D. Freay, K. Kauser, D. Sukovich, G. Burton, D. B. Lubahn, J. F. Couse, S. W. Curtis, and K. S. Korach. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta gender difference and effect of estrogen receptor gene disruption. J. Clin. Invest. 99: 2429-2437, 1997.
26. Treasure, C. B., J. L. Klein, W. S. Weintraub, J. D. Talley, M. E. Stillabower, A. S. Kosinski, J. Zhang, S. J. Boccuzzi, J. C. Cedarholm, and R. W. Alexander. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N. Engl. J. Med. 332: 481-487, 1995.
27. Wang, B. Y., A. H. Singer, P. S. Tsao, H. Drexler, J. Kosek, and J. P. Cooke. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J. Am. Coll. Cardiol. 23: 452-458, 1994.
28. Weiner, C. P., I. Lizasoain, S. Baylis, R. G. Knowles, I. G. Charles, and S. Moncada. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA 88: 5212-5219, 1994.
29. Zeiher, A. M., H. Drexler, H. Wollschläger, and H. Just. Endothelial dysfunction of coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 84: 1984-1992, 1991.